Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001756697-26-000004

Director sold 228 shares at an average $505.87 ($115,338)

  • Director acquired 130 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Mesa Nilda · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-09-14 Exercise or conversion : show line 1 in the form +130 $110.86 $14,412 6,560 D
2026-09-14 Sale : show line 2 in the form −130 $505.79 $65,752 6,430 D
2026-09-14 Sale : show line 3 in the form −98 $505.98 $49,586 5,580 D
Open-market sales · 228 sh · avg $505.87 · $115,338

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-09-14 Exercise or conversion : show line 4 in the form Stock Option −130 6,430 D
Loading xslF345X06/primarydocument.xml…